PRAGUE, Czech Republic, July 30, 2020, a clinical stage immuno-oncology company owned by PPF Group, today announced that Radek Špíšek, chief executive officer of SOTIO, will be presenting a corporate overview at the Private Healthcare Company Virtual Summer Symposium, hosted by LifeSci Partners on August 4 and 5, 2020. Please click the following link to register: https://lifesci.events/SummerSymposium
| Presentation Details: | ||
| Date: | August 5, 2020 | |
| Time: | 10:00 a.m. EDT | |
| Company contact: | Media contact: | |
| Richard Kapsa | Kirsten Frazer, Ph.D. | |
| Head of Communication | LifeSci Communications | |
| T: (+420) 224 174 448 | T: +1 646-863-0222 | |
| M: (+420) 603 280 971 | kfrazer@lifescicomms.com (mailto:kfrazer@lifescicomms.com) | |
| kapsa@sotio.com (mailto:kapsa@sotio.com) |
About SOTIO
SOTIO is shaping the future of cancer immunotherapies by translating compelling science into patient benefit. SOTIO's robust clinical pipeline includes a differentiated superagonist of the attractive immuno-oncology target IL-15, a platform to streamline personalized active immune cell therapies and a new generation of potent and stable antibody-drug conjugates.
SOTIO is a registered trademark of SOTIO a.s. in selected countries.
